Covered recipient · General Payments record
KEA TRESPALACIOS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$2,529.06
- Reported across 107 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $201.61 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $47.03 | 2 |
| ViiV Healthcare Company | $39.82 | 2 |
| Lilly USA, LLC | $32.67 | 2 |
| Abbott Laboratories | $25.93 | 1 |
| Sumitomo Pharma America, Inc. | $23.68 | 1 |
| Acerta Pharma LLC | $17.24 | 1 |
| PFIZER INC. | $15.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $25.93 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125116964 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.24 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104637923 | CMS |
| Gilead Sciences, Inc. | $16.25 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133715247 | CMS |
| Gilead Sciences, Inc. | $30.78 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133715249 | CMS |
| Lilly USA, LLC | $18.40 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135735623 | CMS |
| Lilly USA, LLC | $14.27 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135789866 | CMS |
| PFIZER INC. | $15.24 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132042225 | CMS |
| Sumitomo Pharma America, Inc. | $23.68 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149000394 | CMS |
| ViiV Healthcare Company | $25.54 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112702161 | CMS |
| ViiV Healthcare Company | $14.28 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112700457 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.